Barclays’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,200
| Closed | -$65K | – | 5777 |
|
|
2021
Q4 | $65K | Hold |
7,200
| – | – | ﹤0.01% | 3808 |
|
|
2021
Q3 | $73K | Hold |
7,200
| – | – | ﹤0.01% | 4016 |
|
|
2021
Q2 | $92K | Hold |
7,200
| – | – | ﹤0.01% | 3876 |
|
|
2021
Q1 | $102K | Sell |
7,200
-194,400
| -96% | -$2.68M | ﹤0.01% | 4001 |
|
|
2020
Q4 | $2.15M | Hold |
201,600
| – | – | ﹤0.01% | 2179 |
|
|
2020
Q3 | $1.54M | Hold |
201,600
| – | – | ﹤0.01% | 2324 |
|
|
2020
Q2 | $1.22M | Sell |
201,600
-1,300
| -0.6% | -$6.41K | ﹤0.01% | 2574 |
|
|
2020
Q1 | $714K | Sell |
202,900
-124,100
| -38% | -$1.05M | ﹤0.01% | 3291 |
|
|
2019
Q4 | $3.45M | Sell |
327,000
-68,800
| -17% | -$611K | ﹤0.01% | 2410 |
|
|
2019
Q3 | $4.43M | Buy |
395,800
+63,600
| +19% | +$753K | ﹤0.01% | 1973 |
|
|
2019
Q2 | $3.04M | Buy |
332,200
+61,000
| +22% | +$636K | ﹤0.01% | 2418 |
|
|
2019
Q1 | $3M | Buy |
271,200
+269,000
| +12,227% | +$1.88M | ﹤0.01% | 2141 |
|
|
2018
Q4 | $5K | Sell |
2,200
-8,200
| -79% | -$29.4K | ﹤0.01% | 6471 |
|
|
2018
Q3 | $47K | Sell |
10,400
-2,300
| -18% | -$16.8K | ﹤0.01% | 6120 |
|
|
2018
Q2 | $152K | Sell |
12,700
-1,900
| -13% | -$25.4K | ﹤0.01% | 4956 |
|
|
2018
Q1 | $225K | Sell |
14,600
-15,900
| -52% | -$266K | ﹤0.01% | 4739 |
|
|
2017
Q4 | $499K | Sell |
30,500
-9,600
| -24% | -$186K | ﹤0.01% | 3833 |
|
|
2017
Q3 | $916K | Buy |
40,100
+13,100
| +49% | +$279K | ﹤0.01% | 3085 |
|
|
2017
Q2 | $756K | Buy |
27,000
+18,700
| +225% | +$517K | ﹤0.01% | 3133 |
|
|
2017
Q1 | $255K | Sell |
8,300
-3,800
| -31% | -$107K | ﹤0.01% | 4069 |
|
|
2016
Q4 | $304K | Buy |
12,100
+9,700
| +404% | +$229K | ﹤0.01% | 3828 |
|
|
2016
Q3 | $59K | Buy |
+2,400
| New | +$63.7K | ﹤0.01% | 4882 |
|
|
2015
Q3 | – | Sell |
-100
| Closed | -$4K | – | 7137 |
|
|
2015
Q2 | $4K | Sell |
100
-400
| -80% | -$14.1K | ﹤0.01% | 6598 |
|
|
2015
Q1 | $18K | Sell |
500
-26,800
| -98% | -$903K | ﹤0.01% | 5895 |
|
|
2014
Q4 | $928K | Buy |
27,300
+19,700
| +259% | +$695K | ﹤0.01% | 3280 |
|
|
2014
Q3 | $266K | Buy |
7,600
+4,700
| +162% | +$177K | ﹤0.01% | 4490 |
|
|
2014
Q2 | $116K | Sell |
2,900
-9,600
| -77% | -$368K | ﹤0.01% | 5311 |
|
|
2014
Q1 | $488K | Sell |
12,500
-1,800
| -13% | -$64.8K | ﹤0.01% | 3984 |
|
|
2013
Q4 | $472K | Sell |
14,300
-6,300
| -31% | -$196K | ﹤0.01% | 4155 |
|
|
2013
Q3 | $597K | Buy |
20,600
+12,500
| +154% | +$392K | ﹤0.01% | 3911 |
|
|
2013
Q2 | $273K | Buy |
+8,100
| New | +$251K | ﹤0.01% | 4876 |
|
Barclays's DBD Position: Q3 2023 in Review
Barclays sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2023, closing a stake of 25,865 shares — an estimated $1.37K sold.
Barclays first reported a position in DBD in Q2 2013 and held it in 41 quarters. The position peaked at $4.89M in Q3 2019. 0 funds tracked by Wall St. Rank hold DBD as of Q3 2023.
- Barclays reported no remaining Diebold Nixdorf Incorporated position as of Q3 2023 after selling out during the quarter.
- Barclays sold 25,865 Diebold Nixdorf Incorporated shares in Q3 2023, an estimated $1.37K.
- Barclays first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 41 quarters.
- Barclays's Diebold Nixdorf Incorporated position peaked at $4.89M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2023.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.